Page last updated: 2024-11-12
desmethoxyfallypride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
desmethoxyfallypride: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10404663 |
| CHEMBL ID | 428561 |
| MeSH ID | M0264806 |
Synonyms (12)
| Synonym |
|---|
| CHEMBL428561 , |
| n-(((s)-1-allylpyrrolidin-2-yl)methyl)-5-(3-fluoropropyl)-2-methoxybenzamide |
| bdbm50220544 |
| desmethoxyfallypride |
| dmfp |
| 166173-81-5 |
| 5-(3-fluoropropyl)-2-methoxy-n-(((2s)-1-(2-propen-1-yl)-2-pyrrolidinyl)methyl)benzamide |
| CJD4EF9EME , |
| unii-cjd4ef9eme |
| benzamide, 5-(3-fluoropropyl)-2-methoxy-n-((1-(2-propenyl)-2-pyrrolidinyl)methyl)-, (s)- |
| 5-(3-fluoropropyl)-2-methoxy-n-[[(2s)-1-prop-2-enylpyrrolidin-2-yl]methyl]benzamide |
| DTXSID301031714 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (3)
Inhibition Measurements
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 0.0300 | 0.0000 | 0.6518 | 10.0000 | AID309290; AID309291 |
| D(4) dopamine receptor | Homo sapiens (human) | Ki | 3.0000 | 0.0000 | 0.4362 | 10.0000 | AID309293 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 0.0330 | 0.0000 | 0.6020 | 10.0000 | AID309292 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Biological Processes (124)
Molecular Functions (18)
Ceullar Components (25)
Bioassays (9)
Research
Studies (16)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.44
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.44) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (12.50%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||